Medibank Private Earnings Call Transcripts
Fiscal Year 2026
-
Strong half-year results driven by growth in health insurance and Medibank Health, supported by the Better Medical acquisition and increased customer engagement. Stable margins, robust capital position, and a positive outlook for FY 2026 underpin continued investment and dividend growth.
Fiscal Year 2025
-
The meeting highlighted strong financial growth, increased dividends, and major investments in mental health and primary care. Board renewal and diversity were emphasized, with new directors elected and outgoing members acknowledged. Shareholders approved all resolutions, and strategic plans target significant expansion by 2030.
-
Aspirations include growing health segment earnings to at least AUD 200 million by FY 2030, expanding digital and preventative care, and supporting 10 million people. Strategic investments, innovation in care delivery, and disciplined M&A underpin growth, while system transformation and stakeholder collaboration address rising healthcare demands.
-
Group operating profit rose 8.9% to $762.4 million, with strong growth in both resident and non-resident health insurance and a 27% increase in Medibank Health segment profit. Management expects stable margins, continued disciplined growth, and further M&A investment in FY 2026.
-
Strong financial performance driven by disciplined growth in both resident and non-resident health insurance, robust investment income, and expanding health services. Customer engagement and retention improved through value programs and digital initiatives, while capital position remains strong and M&A pipeline is healthy.
Fiscal Year 2024
-
The AGM highlighted strong financial results, a dividend increase, and ongoing investment in digital health and sustainability. Shareholders approved all resolutions, including board expansion and fee cap increases, while management addressed concerns on technology, diversity, and cyber risk.
-
Solid FY 2024 results with strong profit growth, disciplined market share strategy, and robust capital position. Continued investment in health services, digital innovation, and M&A supports long-term growth, while customer givebacks and productivity savings remain priorities.